Belgium· BE-AMP-SAM666610-00

Dacarbazine Accord 1000 mg

A dacarbazine product containing dacarbazine, registered in Belgium by Accord Healthcare. The same ATC class is registered in 15 of our 19 countries.

ATC L01AX04

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about dacarbazineAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Dacarbazine is registered in 15 of 19 countries.

Countries holding a registration under ATC L01AX04 (dacarbazine), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search dacarbazine products by name

Dacarbazine · ATC L01AX04

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of dacarbazine costs, country by country.

Normalised to the WHO defined daily dose (43.3 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Dacarbazine · price per daily dose (43.3 mg)

USD · FX 28 Sept 2026

CH Switzerland$5.12

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Dacarbazine
Manufacturer: Accord Healthcare
Country: Belgium (BE)
ATC code: L01AX04
ATC class: Dacarbazine
Defined daily dose: 43.3 mg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

237 interactions on record for dacarbazine.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check dacarbazine against other medicines How interaction checks work

Dacarbazine · interactions on record

237 records

35 severe
114 moderate
14 minor
74 info

Most severe, free to view

MipomersenC10AX11severe
LomitapideC10AX12severe
Nalidixic acidJ01MB02severe
CladribineL01BB04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dacarbazine in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dacarbazine products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

Austria · Dacarbazin Lipomed, Dacarbazine Medac
Cyprus · Dacarbazine Lipomed
Czechia · Dacarbazine Medac
Germany · Dacarbazin Lipomed, Detimedac
Denmark · Dacarbazine Lipomed, Dacarbazine Medac
Spain · Dacarbazina Accord, Dacarbazina Medac
Finland · Dacarbazine Lipomed, Dacarbazine Medac
France · Dacarbazine Accord, Dacarbazine Lipomed
United Kingdom (Northern Ireland) · Dacarbazine Medac
Hungary · Dacarbazine Accord, Dacarbazine Lipomed
Ireland · Dacarbazine Lipomed, Dacarbazine Medac
Italy · Dacarbazina Lipomed, Dacarbazina Medac
Netherlands · Dacarbazine Medac
Norway · Dacarbazine Lipomed
Poland · Detimedac
Portugal · Dacarbazina Medac
Romania · Dacarbazina Lipomed
Sweden · Dacarbazine Medac
Slovakia · Dakarbazín Medac

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/11f87f30-f4ba-49ed-9e2a-32455cf4d4c7
GET /v1/drugs/11f87f30-f4ba-49ed-9e2a-32455cf4d4c7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Dacarbazine Accord 1000 mg",
  "name_fr": "Dacarbazine Accord 1000 mg",
  "name_nl": "Dacarbazine Accord 1000 mg",
  "amp_code": "SAM666610-00",
  "strengths": [
    "1000.0000",
    "360.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Dacarbazine",
    "Mannitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Dacarbazine",
  "authorisation_numbers": [
    "BE666610"
  ]
}

API reference MCP server Plans

See everything about dacarbazine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console